EMTRICITABINE/TENOFOVIR ALAFENAMIDE - ORAL
PHONETIC PRONUNCIATION: (EM-trye-SYE-ta-been/ten-OF-oh-vir AL-a-FEN-a-mide)
COMMON BRAND NAME(S): Descovy
GENERIC NAME(S): emtricitabine/tenofovir alafenamide fumarate
Uses
USES: This product is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. Also, it will not always prevent HIV infection. To help prevent becoming infected with HIV and to decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
How to use EMTRICITABINE/TENOFOVIR ALAFENAMIDE - ORAL
HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start taking emtricitabine/tenofovir alafenamide and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take this medication by mouth as directed by your doctor, usually once daily with or without food. The dosage is based on your medical condition and response to treatment. This product is taken with other medicines that treat HIV. If you are also taking didanosine enteric-coated tablets, take both products either on an empty stomach or with a light meal. If you are taking the didanosine buffered tablets, take both drug products on an empty stomach. It is very important to keep taking this medication (and other HIV medications) exactly as prescribed by your doctor. Do not skip any doses. For the best effect, take this medication at evenly spaced times. To help you remember, take this medication at the same time every day. Do not take more or less of this drug than prescribed or stop taking it (or other HIV medicines) even for a short time unless directed to do so by your doctor. Doing so may cause the amount of virus to increase, make the infection more difficult to treat (resistant), or worsen side effects.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for EMTRICITABINE/TENOFOVIR ALAFENAMIDE - ORAL
Emtricitabine/Tenofovir Alafenamide (TAF) is an oral medication used for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg.
Emtricitabine/Tenofovir Alafenamide (TAF) is a combination of two antiretroviral drugs that work by inhibiting the reverse transcriptase enzyme, which is necessary for the replication of HIV-1 virus. It helps to reduce the viral load and improve the immune system.
Common side effects of Emtricitabine/Tenofovir Alafenamide (TAF) may include diarrhea, nausea, headache, tiredness, dizziness, and abnormal dreams. However, not everyone experiences these side effects, and they usually resolve on their own.
Emtricitabine/Tenofovir Alafenamide (TAF) is usually taken once daily with or without food. It is important to take the medication as prescribed by your healthcare provider to ensure its maximum effectiveness.
Emtricitabine/Tenofovir Alafenamide (TAF) may interact with certain medications, including those used to treat hepatitis C, certain anticonvulsants, and antacids containing aluminum or magnesium. Inform your healthcare provider about all the medications you are taking to avoid any potential interactions.
No, Emtricitabine/Tenofovir Alafenamide (TAF) is not a cure for HIV. It helps to control the virus and reduce the viral load, but it does not eliminate the HIV infection. It is important to continue taking the medication as prescribed to maintain its effectiveness.
Moderate alcohol consumption is generally considered acceptable, but excessive alcohol intake may worsen the side effects of Emtricitabine/Tenofovir Alafenamide (TAF) or affect its effectiveness. It is best to consult your healthcare provider regarding alcohol consumption while on this medication.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
Emtricitabine/Tenofovir Alafenamide (TAF) is not approved as a preventative measure against HIV transmission but is specifically used for the treatment of HIV-1 infection. Pre-exposure prophylaxis (PrEP) medications like Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) are often recommended for individuals at risk of HIV infection.
Warning
WARNING: If you have hepatitis B infection as well as HIV, your hepatitis symptoms may get worse or become very serious if you stop taking this medication. Talk with your doctor before stopping this medication. Your doctor will check liver function tests for several months after you stop.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet